Pharmaceutical Lipid-based Excipients Market Growth & Trends
The global pharmaceutical lipid-based excipients market size is anticipated to reach USD 2.42 billion by 2030 and is anticipated to expand at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of poorly soluble drug candidates, representing 87% of pipeline candidates, has driven the adoption of advanced excipient solutions. Lipid-based excipients such as solid lipid nanoparticles and self-emulsifying drug delivery systems have become essential for complex molecules, addressing formulation challenges effectively. This surge reflects the pharmaceutical industry’s need for innovative solutions to enhance drug bioavailability and efficacy.
The integration of lipid-based excipients has revolutionized mRNA vaccines and gene therapies, as highlighted during the COVID-19 pandemic. Moreover, the demand for cost-effective excipients has further increased due to patent expirations for major pharmaceutical drugs. These factors underscore the transformative impact of lipid excipients on modern pharmaceutical development and their role in driving innovation in drug delivery.
Advancements in artificial intelligence (AI) and formulation technologies further contribute to the growth of the lipid excipients market. AI-driven modeling accelerates lipid based formulations, enhancing predictability and reducing time-to-market. Regulatory bodies maintain high expectations for lipid excipients, prioritizing patient safety by focusing on purity and safety characteristics, ultimately ensuring the quality and effectiveness of pharmaceutical products.
Pharmaceutical Lipid-based Excipients Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook